The Make America Healthy Again (MAHA) Commission, as established by President Donald Trump's Feb. 13, 2025, Executive Order (EO) 14212, released its inaugural report on May 22, 2025, titled "The MAHA Report: Making Our...more
5/27/2025
/ Artificial Intelligence ,
Chemicals ,
Clinical Trials ,
Environmental Protection Agency (EPA) ,
Food and Drug Administration (FDA) ,
Food Manufacturers ,
Food Supply ,
Information Reports ,
Pesticides ,
Prescription Drugs ,
Public Health ,
Regulatory Reform ,
Toxic Chemicals ,
Trump Administration
U.S. House of Representatives committees are scheduled to begin markups on additional portions of the budget reconciliation package on May 13, 2025. Both the House Committee on Ways and Means and the House Committee on Energy...more
5/14/2025
/ Administrative Appointments ,
Artificial Intelligence ,
Budget Reconciliation ,
Children's Health Insurance Program (CHIP) ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Food and Drug Administration (FDA) ,
Healthcare ,
Legislative Agendas ,
Medicaid ,
Medical Research ,
Medicare ,
Medicare Part D ,
National Institute of Health (NIH) ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Proposed Legislation ,
Supply Chain ,
Trump Administration
Looking Ahead: House to Vote on Compromise Budget Resolution On the heels of the U.S. Senate's passage of a compromise budget resolution, the U.S. House of Representatives is expected to consider the budget resolution on the...more
4/9/2025
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Drug Pricing ,
Executive Orders ,
Federal Budget ,
Federal Grants ,
Healthcare ,
Legislative Agendas ,
MACPAC ,
Medicare ,
Medicare Part D ,
MedPAC ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Regulatory Agenda ,
Tariffs ,
Trump Administration
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/20/2025
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Agenda ,
Senate Confirmation Hearings
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
12/27/2024
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Consolidated Appropriations Act (CAA) ,
Department of Health and Human Services (HHS) ,
Explanation of Benefits (EOBs) ,
Final Rules ,
Health Care Providers ,
Hospitals ,
MACPAC ,
Medicare ,
MedPAC
In 2025, Republicans will hold the majority in both chambers of Congress, and the incoming Trump Administration will preside over the executive branch. For healthcare issues at the intersection of access and equity, this...more
11/21/2024
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Deregulation ,
Diversity and Inclusion Standards (D&I) ,
Election Results ,
Healthcare ,
Legislative Agendas ,
Life Sciences ,
Loper Bright Enterprises v Raimondo ,
Members of Congress ,
Popular ,
Regulatory Agenda ,
Rural Health Care Providers ,
Telehealth ,
Trump Administration
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
9/13/2024
/ Artificial Intelligence ,
Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Continuing Resolution ,
DEA ,
Department of Health and Human Services (HHS) ,
Department of Labor (DOL) ,
Federal Funding ,
Final Rules ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Medicare ,
Medicare Part B ,
MedPAC ,
Mental Health ,
Mental Health Parity Rule ,
Prescription Drugs ,
Reproductive Healthcare Issues ,
Telehealth ,
U.S. Treasury
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
7/26/2024
/ Artificial Intelligence ,
Chevron Deference ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Hospitals ,
Information Reports ,
Loper Bright Enterprises v Raimondo ,
Microsoft ,
Pharmacy Benefit Manager (PBM) ,
Presidential Elections
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
5/23/2024
/ Artificial Intelligence ,
Center for Biologics Evaluation and Research (CBER) ,
Clinical Trials ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Cybersecurity ,
Diversity ,
Drug Pricing ,
Federal Budget ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Industry Consolidation ,
Medicare ,
Opioid ,
Physician Fee Schedule ,
Prescription Drugs ,
Prior Authorization ,
Proposed Legislation
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
5/1/2024
/ ACOs ,
Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Medicare ,
OCR ,
Prescription Drugs ,
Proposed Legislation ,
Surprise Medical Bills
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more
3/7/2024
/ Appropriations Bill ,
Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Federal Funding ,
Federal Trade Commission (FTC) ,
Final Rules ,
Health Care Providers ,
Health Insurance ,
Legislative Agendas ,
Medicaid ,
Medicare Advantage ,
Medicare Part D ,
MedPAC ,
MIPS ,
National Institute of Health (NIH) ,
OMB ,
Pediatrics ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drug Coverage ,
Prescription Drugs ,
Private Equity ,
Proposed Legislation ,
Public Comment ,
Public Health ,
Reproductive Healthcare Issues ,
Request For Information ,
Working Groups
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/28/2024
/ Affordable Care Act ,
Appropriations Bill ,
Artificial Intelligence ,
Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Clinical Trials ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Dear Colleague Letter ,
Diversity ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Information Reports ,
Medical Research ,
National Institute of Health (NIH) ,
PHI ,
Political Parties ,
Prescription Drugs ,
Research and Development ,
Webinars
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
1/24/2024
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Chevron Deference ,
Congressional Committees ,
Continuing Resolution ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Dispute Resolution ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicaid ,
Medical Research ,
Medicare ,
Mental Health ,
Prescription Drugs ,
World Health Organization